Published date: 21 September 2020

Awarded contract - This means that the contract has been awarded to a supplier.


Closing: 12 February 2020, 1pm

Contract summary

Industry

  • Research and development services and related consultancy services - 73000000

Location of contract

United Kingdom

Value of contract

£388,378

Procurement reference

108322/KENSA01

Published date

21 September 2020

Closing date

12 February 2020

Closing time

1pm

Contract start date

25 June 2020

Contract end date

31 December 2020

Contract type

Service contract

Procedure type

Other: Private procurement rules

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

Yes


Private procurement rules

Supply chain notices are business-to-business transactions and are not bound by the same rules and restrictions as public sector contracts. The UK government is not responsible for the conduct of such procurement.


Description

Accelerating the Sustainable Control and Elimination of NTDs (ASCEND) is an investment from the UK Government's Foreign, Commonwealth and Development Office (FCDO) to advance the impact and sustainability of national programme's tackling neglected tropical diseases (NTDs). ASCEND in South Asia, East and Southern Africa is implemented by a consortium of technical partners led by Crown Agents.

Under the ASCEND programme, Crown Agents has awarded a subcontract to an Implementing Partner to provide services which promote the national goal of prevention and control of Visceral Leishmaniasis in all endemic areas in Kenya by:
• improving timely diagnosis and treatment of VL;
• strengthening surveillance, monitoring and evaluation and use of data to inform operational plans and improve response to emerging outbreaks;
• sustaining and strengthening the existing VL treatment facilities and activities.


Award information

Awarded date

25 June 2020

Contract start date

25 June 2020

Contract end date

31 December 2020

Total value of contract

£388,378

This contract was awarded to 1 supplier.

Foundation for New Innovative Diagnostics (FIND)

Address

Campus Biotech
Chemin des Mines 9
1202 Geneva
Switzerland

Reference

No reference - other

Value of contract

£388,378

Supplier is SME?

No

Supplier is VCSE?

No